BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24355563)

  • 1. Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling.
    Koval AV; Vlasov P; Shichkova P; Khunderyakova S; Markov Y; Panchenko J; Volodina A; Kondrashov FA; Katanaev VL
    Biochem Pharmacol; 2014 Feb; 87(4):571-8. PubMed ID: 24355563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor.
    Ahmed K; Koval A; Xu J; Bodmer A; Katanaev VL
    Cancer Lett; 2019 May; 449():45-55. PubMed ID: 30771433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
    Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
    Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt-Fzd signaling sensitizes peripheral sensory neurons via distinct noncanonical pathways.
    Simonetti M; Agarwal N; Stösser S; Bali KK; Karaulanov E; Kamble R; Pospisilova B; Kurejova M; Birchmeier W; Niehrs C; Heppenstall P; Kuner R
    Neuron; 2014 Jul; 83(1):104-21. PubMed ID: 24991956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells.
    Maubant S; Tesson B; Maire V; Ye M; Rigaill G; Gentien D; Cruzalegui F; Tucker GC; Roman-Roman S; Dubois T
    PLoS One; 2015; 10(4):e0122333. PubMed ID: 25848952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo.
    Koval A; Bassanini I; Xu J; Tonelli M; Boido V; Sparatore F; Amant F; Annibali D; Leucci E; Sparatore A; Katanaev VL
    Eur J Med Chem; 2021 Oct; 222():113562. PubMed ID: 34116325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
    Wang J; Qi H; Zhang X; Si W; Xu F; Hou T; Zhou H; Wang A; Li G; Liu Y; Fang Y; Piao HL; Liang X
    Biomed Pharmacother; 2018 Dec; 108():724-733. PubMed ID: 30248540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells.
    López-Herradón A; Portal-Núñez S; García-Martín A; Lozano D; Pérez-Martínez FC; Ceña V; Esbrit P
    J Cell Biochem; 2013 Aug; 114(8):1908-16. PubMed ID: 23494914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
    Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
    Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
    Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.
    Xie W; Zhang Y; He Y; Zhang K; Wan G; Huang Y; Zhou Z; Huang G; Wang J
    Int J Biochem Cell Biol; 2018 Oct; 103():45-55. PubMed ID: 30096373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tannins from Syzygium guineense suppress Wnt signaling and proliferation of Wnt-dependent tumors through a direct effect on secreted Wnts.
    Koval A; Pieme CA; Queiroz EF; Ragusa S; Ahmed K; Blagodatski A; Wolfender JL; Petrova TV; Katanaev VL
    Cancer Lett; 2018 Oct; 435():110-120. PubMed ID: 30098400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt3a stimulates Mepe, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression.
    Cho YD; Kim WJ; Yoon WJ; Woo KM; Baek JH; Lee G; Kim GS; Ryoo HM
    J Cell Physiol; 2012 Jun; 227(6):2287-96. PubMed ID: 22213482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin regulates parathyroid hormone/parathyroid hormone-related protein receptor signals and chondrocyte hypertrophy through binding to the intracellular C-terminal region of the receptor.
    Yano F; Saito T; Ogata N; Yamazawa T; Iino M; Chung UI; Kawaguchi H
    Arthritis Rheum; 2013 Feb; 65(2):429-35. PubMed ID: 23124878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of R-spondins in triple-negative and metaplastic breast cancers.
    Coussy F; Lallemand F; Vacher S; Schnitzler A; Chemlali W; Caly M; Nicolas A; Richon S; Meseure D; El Botty R; De-Plater L; Fuhrmann L; Dubois T; Roman-Roman S; Dangles-Marie V; Marangoni E; Bièche I
    Br J Cancer; 2017 Jun; 116(12):1595-1603. PubMed ID: 28472820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of clofazimine in dermatology.
    Gurfinkel P; Pina JC; Ramos-e-Silva M
    J Drugs Dermatol; 2009 Sep; 8(9):846-51. PubMed ID: 19746677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding.
    Shultz MD; Kirby CA; Stams T; Chin DN; Blank J; Charlat O; Cheng H; Cheung A; Cong F; Feng Y; Fortin PD; Hood T; Tyagi V; Xu M; Zhang B; Shao W
    J Med Chem; 2012 Feb; 55(3):1127-36. PubMed ID: 22260203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology, metabolism, and chemistry of clofazimine.
    O'Connor R; O'Sullivan JF; O'Kennedy R
    Drug Metab Rev; 1995; 27(4):591-614. PubMed ID: 8925720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.